| Model Number |
900SFC230 |
| Medical Device Problem Codes |
Insufficient Device Problem Information (3190); Intravalvular regurgitation (4068)
|
| Health Effect - Clinical Codes |
Chest Pain (1776); Dyspnea (1816); Syncope/Fainting (4411); Tricuspid Valve Insufficiency/ Regurgitation (4453); Insufficient Information (4580)
|
| Date of Event |
11/07/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Medtronic received information that 5 years and 1 month post implant of this 23mm tricuspid annuloplasty band, it was explanted and replaced with a 31mm bioprosthetic valve.The reason for the replacement was not reported.No additional adverse patient effects were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Correction: b5 - size of tricuspid annuloplasty band corrected from 23mm to 30mm.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Medtronic received information that 5 years and 1 month post implant of this 30mm tricuspid annuloplasty band, it was explanted and replaced with a 31mm bioprosthetic valve.The reason for the replacement was not reported.No additional adverse patient effects were reported.Additional information was received that reported the reason for replacement as moderate to severe tricuspid regurgitation.It was also reported that the patient presented to the hospital with symptoms of chest pain, dyspnea and syncope.No additional adverse patient effects were reported.
|
| |
|
Event or Problem Description
|
|
Additional information was received that reported the reason for replacement as moderate to severe tricuspid regurgitation.It was also reported that the patient presented to the hospital with symptoms of chest pain, dyspnea and syncope.No additional adverse patient effects were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated data: a.4: patient weight b.1: adv evnt/prod prob: b.2: outcome attributed to adverse event b.5: event description b.7: relevant history h.6: coding.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|